Funds holding VanEck Biotech ETF
ISIN US92189F7261 · United States · LEI 549300PGHG6VYS4R2K51
- Fund holders
- 1
- Of which ETFs
- 1 0 other funds
- Value held
- 56.6K $
A single tracked fund declares this security. So these figures do not say who holds it.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| AB US Equity ETF AB Active ETFs, Inc. | 300 | 56.6K $ | 0.01 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of this security in each fund.
| Fund | Weight in fund | |
|---|---|---|
| AB US Equity ETF AB Active ETFs, Inc. | 0.01 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 1 | 0 | 300 | 0.0 % |
| 2026Q2 | 1 | 300 |
Institutional managers
110 managers declare this security to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 102,079 | 19.2M $ | as of Mar 31, 2026 |
| RAYMOND JAMES FINANCIAL INC | 69,560 | 13.1M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 66,338 | 12.5M $ | as of Mar 31, 2026 |
| Ascent Advisors, LLC | 59,450 | 2.7M $ | as of Mar 31, 2026 |
| Miller Investment Management, LP | 38,962 | 7.3M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 32,916 | 6.2M $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 32,821 | 6.2M $ | as of Mar 31, 2026 |
| LPL Financial LLC | 26,551 | 5M $ | as of Mar 31, 2026 |
| Conservest Capital Advisors, Inc. | 20,276 | 3.8M $ | as of Mar 31, 2026 |
| UBS Group AG | 16,593 | 3.1M $ | as of Mar 31, 2026 |
| Bleakley Financial Group, LLC | 15,423 | 2.9M $ | as of Mar 31, 2026 |
| Paragon Private Wealth Management, LLC | 15,368 | 2.9M $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 13,843 | 2.6M $ | as of Mar 31, 2026 |
| Rockefeller Capital Management L.P. | 11,862 | 2.2M $ | as of Mar 31, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | 10,040 | 1.9M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 9,514 | 1.8M $ | as of Mar 31, 2026 |
| ALTFEST L J & CO INC | 8,507 | 1.6M $ | as of Mar 31, 2026 |
| Institute for Wealth Management, LLC. | 7,439 | 1.4M $ | as of Mar 31, 2026 |
| STIFEL FINANCIAL CORP | 7,300 | 1.4M $ | as of Mar 31, 2026 |
| PEAPACK GLADSTONE FINANCIAL CORP | 7,203 | 1.4K $ | as of Mar 31, 2026 |
| Wealthfront Advisers LLC | 7,004 | 1.3M $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 6,551 | 1.2M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 6,100 | 1.1M $ | as of Mar 31, 2026 |
| Cerity Partners LLC | 5,553 | 1M $ | as of Mar 31, 2026 |
| ATLAS CAPITAL ADVISORS INC. | 5,450 | 1M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding VanEck Biotech ETF". https://titelia.com/en/stocks/vaneck-biotech-etf-US92189F7261